Gemcitabine, capecitabine, and tislelizumab in recurrent/metastatic nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A retrospective study
Titel:
Gemcitabine, capecitabine, and tislelizumab in recurrent/metastatic nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A retrospective study
Auteur:
Yang, Rui Li, Ruichen Niu, Xiaoshuang Zhao, Yang Yan, Li Tian, Shu Zhu, Yi Qiu, JianJian Wang, Xiaoshen